Palliative effect of (131)I-MIBG in relapsed neuroblastoma after autologous peripheral blood stem cell transplantation / 소아과
Korean Journal of Pediatrics
;
: 214-218, 2008.
Artículo
en Inglés
| WPRIM
| ID: wpr-94452
ABSTRACT
Neuroblastoma is one of the most common extracranial solid tumor of childhood, and treatment of refractory neuroblastoma remains a significant clinical problem. Iodine-131-metaiodobenzylguanidine ((131)I-MIBG) therapy is an alternative approach to treat stage IV neuroblastoma. We report the palliative effect of (131)I-MIBG in three cases of relapsed neuroblastoma after autologous peripheral blood stem cell transplantation. (131)I-MIBG is an effective and relatively nontoxic palliative therapy resulting in reduction of pain and prolongation of survival.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Cuidados Paliativos
/
Trasplante de Células Madre de Sangre Periférica
/
Neuroblastoma
Idioma:
Inglés
Revista:
Korean Journal of Pediatrics
Año:
2008
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS